Newstral
Article
bizjournals.com on 2016-12-19 20:53
This Cambridge biotech CEO just bought an $8M condo in Millennium Tower
Related news
- Former head of Millennium to head Cambridge biotech startup Mersanabizjournals.com
- Cambridge biotech delivers coronavirus vaccinebizjournals.com
- Cambridge biotech plans manufacturing hub in Marylandbizjournals.com
- Cambridge biotech Werewolf gets $72M funding roundbizjournals.com
- Biotech startup expands from Cambridge to Watertownbizjournals.com
- Cambridge biotech to return its PPP loanbizjournals.com
- Cambridge biotech relocates to West Coastbizjournals.com
- Michael Dell pays $11M for Millennium Tower condobizjournals.com
- BOn the Market: A Millennium Tower Condo with Gorgeous Viewsbostonmagazine.com
- Exclusive: Millennium Tower condo sells for 30 percent lossbizjournals.com
- Millennium Tower Condo Owners Want SF to Cancel Property TaxNBC Bay Area
- Millennium Tower slashes price of city's most expensive condobizjournals.com
- Long-delayed Cambridge condo project breaks groundbizjournals.com
- BThis Designer’s Cambridge Condo is Delightfully Quirkybostonmagazine.com
- £8m funding for CRUK Cambridge Centre for radiotherapy researchcambridgeindependent.co.uk
- Kraft Group participates in $30M funding for Cambridge biotechbizjournals.com
- Cambridge biotech developing cystic fibrosis drug seeks $86M IPObizjournals.com
- Shares of Cambridge biotech Sarepta crash after harsh FDA reviewbizjournals.com
- A ‘hacker house’ for young biotech leaders opens in Cambridgebizjournals.com
- Picture this: Fujifilm invests in Cambridge biotech startupbizjournals.com